Rakhee Chauhan

The biology and trafficking of the FMS receptor

R. Chauhan, Rakhee Chauhan, 2014 .

Mechanistic insight into RET kinase inhibitors targeting the DFG-out conformation in RET-rearranged cancer

K. Shokat, Roman K. Thomas, M. Peifer, 2017 .

Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors

K. Shokat, Roman K. Thomas, M. Peifer, 2017, Science Translational Medicine.

RET Functions as a Dual-Specificity Kinase that Requires Allosteric Inputs from Juxtamembrane Elements

I. Plaza-Menacho, K. Barnouin, N. McDonald, 2016, Cell reports.

Novel Imatinib Derivatives with Altered Specificity between Bcr–Abl and FMS, KIT, and PDGF Receptors

S. Kiriakidis, A. Tzakos, N. Dibb, 2010, ChemMedChem.

Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology

Naga Rajiv Lakkaniga, M. Santoro, N. McDonald, 2020, Journal of medicinal chemistry.

A secondary RET mutation in the activation loop conferring resistance to vandetanib

T. Kohno, Y. Okuno, K. Tsumoto, 2018, Nature Communications.

Activation of the receptor tyrosine kinase, RET, improves long-term hematopoietic stem cell outgrowth and potency.

N. McDonald, W. Grey, M. Garcia-Albornoz, 2020, Blood.